456 related articles for article (PubMed ID: 15808248)
1. Late onset is common in best macular dystrophy associated with VMD2 gene mutations.
Renner AB; Tillack H; Kraus H; Krämer F; Mohr N; Weber BH; Foerster MH; Kellner U
Ophthalmology; 2005 Apr; 112(4):586-92. PubMed ID: 15808248
[TBL] [Abstract][Full Text] [Related]
2. Variant phenotype of Best vitelliform macular dystrophy associated with compound heterozygous mutations in VMD2.
Schatz P; Klar J; Andréasson S; Ponjavic V; Dahl N
Ophthalmic Genet; 2006 Jun; 27(2):51-6. PubMed ID: 16754206
[TBL] [Abstract][Full Text] [Related]
3. Course of visual decline in relation to the Best1 genotype in vitelliform macular dystrophy.
Booij JC; Boon CJ; van Schooneveld MJ; ten Brink JB; Bakker A; de Jong PT; Hoyng CB; Bergen AA; Klaver CC
Ophthalmology; 2010 Jul; 117(7):1415-22. PubMed ID: 20381869
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the VMD2 gene in thai families with best macular dystrophy.
Atchaneeyasakul LO; Jinda W; Sakolsatayadorn N; Trinavarat A; Ruangvoravate N; Thanasombatskul N; Thongnoppakhun W; Limwongse C
Ophthalmic Genet; 2008 Sep; 29(3):139-44. PubMed ID: 18766995
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration.
Krämer F; White K; Pauleikhoff D; Gehrig A; Passmore L; Rivera A; Rudolph G; Kellner U; Andrassi M; Lorenz B; Rohrschneider K; Blankenagel A; Jurklies B; Schilling H; Schütt F; Holz FG; Weber BH
Eur J Hum Genet; 2000 Apr; 8(4):286-92. PubMed ID: 10854112
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of Stargardt's disease and fundus flavimaculatus.
Armstrong JD; Meyer D; Xu S; Elfervig JL
Ophthalmology; 1998 Mar; 105(3):448-57; discussion 457-8. PubMed ID: 9499775
[TBL] [Abstract][Full Text] [Related]
7. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options.
Boon CJ; van den Born LI; Visser L; Keunen JE; Bergen AA; Booij JC; Riemslag FC; Florijn RJ; van Schooneveld MJ
Ophthalmology; 2013 Apr; 120(4):809-20. PubMed ID: 23290749
[TBL] [Abstract][Full Text] [Related]
8. Morphology and functional characteristics in adult vitelliform macular dystrophy.
Renner AB; Tillack H; Kraus H; Kohl S; Wissinger B; Mohr N; Weber BH; Kellner U; Foerster MH
Retina; 2004 Dec; 24(6):929-39. PubMed ID: 15579992
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of macular structure and function by OCT and electrophysiology in patients with vitelliform macular dystrophy due to mutations in BEST1.
Schatz P; Bitner H; Sander B; Holfort S; Andreasson S; Larsen M; Sharon D
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4754-65. PubMed ID: 20375334
[TBL] [Abstract][Full Text] [Related]
10. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.
Renner AB; Kellner U; Cropp E; Preising MN; MacDonald IM; van den Hurk JA; Cremers FP; Foerster MH
Ophthalmology; 2006 Nov; 113(11):2066.e1-10. PubMed ID: 16935340
[TBL] [Abstract][Full Text] [Related]
11. Allelic variation in the VMD2 gene in best disease and age-related macular degeneration.
Lotery AJ; Munier FL; Fishman GA; Weleber RG; Jacobson SG; Affatigato LM; Nichols BE; Schorderet DF; Sheffield VC; Stone EM
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1291-6. PubMed ID: 10798642
[TBL] [Abstract][Full Text] [Related]
12. A reappraisal of the clinical spectrum of North Carolina macular dystrophy.
Khurana RN; Sun X; Pearson E; Yang Z; Harmon J; Goldberg MF; Zhang K
Ophthalmology; 2009 Oct; 116(10):1976-83. PubMed ID: 19616854
[TBL] [Abstract][Full Text] [Related]
13. Autologous transplantation of retinal pigment epithelium-Bruch's membrane complex for hemorrhagic age-related macular degeneration.
Ma Z; Han L; Wang C; Dou H; Hu Y; Feng X; Xu Y; Wang Z; Yin Z; Liu Y
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2975-81. PubMed ID: 19117919
[TBL] [Abstract][Full Text] [Related]
14. Retinal function in best macular dystrophy: relationship between electrophysiological, psychophysical, and structural measures of damage.
Maia-Lopes S; Silva ED; Reis A; Silva MF; Mateus C; Castelo-Branco M
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5553-60. PubMed ID: 18775865
[TBL] [Abstract][Full Text] [Related]
15. Fundus autofluorescence in carriers of choroideremia and correlation with electrophysiologic and psychophysical data.
Preising MN; Wegscheider E; Friedburg C; Poloschek CM; Wabbels BK; Lorenz B
Ophthalmology; 2009 Jun; 116(6):1201-9.e1-2. PubMed ID: 19376587
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy.
Tyni T; Kivelä T; Lappi M; Summanen P; Nikoskelainen E; Pihko H
Ophthalmology; 1998 May; 105(5):810-24. PubMed ID: 9593380
[TBL] [Abstract][Full Text] [Related]
17. Best's vitelliform macular dystrophy caused by a new mutation (Val89Ala) in the VMD2 gene.
Eksandh L; Bakall B; Bauer B; Wadelius C; Andréasson S
Ophthalmic Genet; 2001 Jun; 22(2):107-15. PubMed ID: 11449320
[TBL] [Abstract][Full Text] [Related]
18. VMD2 mutations in vitelliform macular dystrophy (Best disease) and other maculopathies.
White K; Marquardt A; Weber BH
Hum Mutat; 2000; 15(4):301-8. PubMed ID: 10737974
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular genetic analysis of best vitelliform macular dystrophy.
Boon CJ; Theelen T; Hoefsloot EH; van Schooneveld MJ; Keunen JE; Cremers FP; Klevering BJ; Hoyng CB
Retina; 2009 Jun; 29(6):835-47. PubMed ID: 19357557
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of 14 japanese patients with X-linked juvenile retinoschisis associated with XLRS1 mutation.
Shinoda K; Ishida S; Oguchi Y; Mashima Y
Ophthalmic Genet; 2000 Sep; 21(3):171-80. PubMed ID: 11035549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
